Drug Shortage Report for REPAGLINIDE
Report ID | 102499 |
Drug Identification Number | 02415976 |
Brand name | REPAGLINIDE |
Common or Proper name | REPAGLINIDE |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | REPAGLINIDE |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A10BX |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-01-07 |
Estimated end date | 2020-01-21 |
Actual end date | 2020-01-17 |
Shortage status | Resolved |
Updated date | 2020-01-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-01-07 | English | Compare |
v2 | 2020-01-07 | French | Compare |
v3 | 2020-01-08 | English | Compare |
v4 | 2020-01-17 | English | Compare |
v5 | 2020-01-17 | French | Compare |
v6 | 2020-01-18 | English | Compare |
Showing 1 to 6 of 6